F. Perry Wilson, MD, MSCE, shares insights from a review of recent study results published in the New England Journal of Medicine examining duty-hours rules at 63 residency…
NEW YORK (Reuters Health) – Cephalocaudal jaundice progression does not correlate with bilirubin levels, especially in late-term premature infants, a new prospective study shows. Visual assessment of jaundice…
NEW YORK (Reuters Health) – Given together, nortriptyline and gabapentin are more effective than either agent alone in treating neuropathic pain, according to a report in the September…
NEW YORK (Reuters Health) – In most patients with Crohn’s disease, endoscopic findings have relatively little impact on clinical decision making, results of a study conducted in Italy…
NEW YORK (Reuters Health) – Treatment of mild gestational diabetes mellitus (GDM) cut the risks of fetal overgrowth, shoulder dystocia, cesarean delivery, and hypertensive disorders in a study…
NEW YORK (Reuters Health) – Bilirubin screening in all infants could reduce the incidence of severe hyperbilirubinemia, but at the same time increase use of phototherapy at bilirubin…
NEW YORK (Reuters Health) – Supplementation with vitamin C enhances the success of Helicobacter pylori eradication efforts, say researchers from Iran. Vitamin C has been shown to inhibit…
NEW YORK (Reuters Health) – For patients with primary cutaneous melanoma, targeted high-resolution ultrasound should not be used as a substitute for excisional sentinal lymph node biopsy, new…
NEW YORK (Reuters Health) – In young women, the presence of lupus anticoagulant is associated with a more than 40-fold increased risk of stroke and 5-fold increased risk…
NEW YORK (Reuters Health) – In response, in part, to the availability of new vaccines, the Infectious Diseases Society of America has issued an update to their 2002…
NEW YORK (Reuters Health) – Gastrointestinal bleeding in patients with acute coronary syndromes (ACS) is independently associated with high rates of mortality, myocardial infarction and stent thrombosis, researchers…
